AstraZeneca bolsters cancer pipeline with partnerships

The News JournalAstraZeneca bolsters cancer pipeline with partnershipsThe News JournalIn a second agreement, AztraZeneca's MedImmune subsidiary will partner with Little Mirati Therapeutics, a San Diego company, to market Little Mirati's experimental non-small cell lung cancer therapy known as MEDI4736. Terms of the transaction were not ...and more »

Share this post